JP5998211B2 - マグネシウムのスクロースオクタ硫酸エステル、その製造方法およびその医薬的および美容的使用 - Google Patents

マグネシウムのスクロースオクタ硫酸エステル、その製造方法およびその医薬的および美容的使用 Download PDF

Info

Publication number
JP5998211B2
JP5998211B2 JP2014513184A JP2014513184A JP5998211B2 JP 5998211 B2 JP5998211 B2 JP 5998211B2 JP 2014513184 A JP2014513184 A JP 2014513184A JP 2014513184 A JP2014513184 A JP 2014513184A JP 5998211 B2 JP5998211 B2 JP 5998211B2
Authority
JP
Japan
Prior art keywords
sucrose octasulfate
magnesium
salt
solution
sucrose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2014513184A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014515388A5 (cg-RX-API-DMAC7.html
JP2014515388A (ja
Inventor
セブラン、ジュラン
エレーヌ、エルナンデス−ピジョン
リュック、アギラール
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Dermo Cosmetique SA
Original Assignee
Pierre Fabre Dermo Cosmetique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Dermo Cosmetique SA filed Critical Pierre Fabre Dermo Cosmetique SA
Publication of JP2014515388A publication Critical patent/JP2014515388A/ja
Publication of JP2014515388A5 publication Critical patent/JP2014515388A5/ja
Application granted granted Critical
Publication of JP5998211B2 publication Critical patent/JP5998211B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/08—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to sulfur, selenium or tellurium
    • C07H5/10—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to sulfur, selenium or tellurium to sulfur

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
JP2014513184A 2011-05-31 2012-05-31 マグネシウムのスクロースオクタ硫酸エステル、その製造方法およびその医薬的および美容的使用 Active JP5998211B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1154752 2011-05-31
FR1154752A FR2975993B1 (fr) 2011-05-31 2011-05-31 Sucroses octasulfates de magnesium, leur preparation et leurs applications pharmaceutiques et cosmetiques
PCT/EP2012/060211 WO2012163997A1 (fr) 2011-05-31 2012-05-31 Sucroses octasulfates de magnesium, leur preparation et leurs applications pharmaceutiques et cosmetiques

Publications (3)

Publication Number Publication Date
JP2014515388A JP2014515388A (ja) 2014-06-30
JP2014515388A5 JP2014515388A5 (cg-RX-API-DMAC7.html) 2015-07-02
JP5998211B2 true JP5998211B2 (ja) 2016-09-28

Family

ID=46197271

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014513184A Active JP5998211B2 (ja) 2011-05-31 2012-05-31 マグネシウムのスクロースオクタ硫酸エステル、その製造方法およびその医薬的および美容的使用

Country Status (8)

Country Link
US (1) US9562065B2 (cg-RX-API-DMAC7.html)
EP (1) EP2714705B1 (cg-RX-API-DMAC7.html)
JP (1) JP5998211B2 (cg-RX-API-DMAC7.html)
ES (1) ES2541476T3 (cg-RX-API-DMAC7.html)
FR (1) FR2975993B1 (cg-RX-API-DMAC7.html)
PL (1) PL2714705T3 (cg-RX-API-DMAC7.html)
PT (1) PT2714705E (cg-RX-API-DMAC7.html)
WO (1) WO2012163997A1 (cg-RX-API-DMAC7.html)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1390007A (fr) 1964-04-13 1965-02-19 Plage permettant d'intégrer sur un disque un enregistrement publicitaire ou autre
US4098995A (en) * 1976-07-12 1978-07-04 American Cyanamid Company Polygalactosido-sucrose poly(h-)sulfate salts
AU607690B2 (en) 1985-12-24 1991-03-14 Marion Laboratories, Inc. Use of synthetic sulfated saccharides to enhance wound healing
US5916880A (en) * 1987-12-21 1999-06-29 Bukh Meditec A/S Reduction of skin wrinkling using sulphated sugars
DK505488D0 (da) * 1987-12-21 1988-09-09 Bar Shalom Daniel Middel og anvendelse af samme
DK505588D0 (da) * 1988-02-26 1988-09-09 Jesper Hamburger Middel og anvendelse af samme
US5618798A (en) * 1989-04-20 1997-04-08 Bar-Shalom; Daniel Use of sucralfate to treat baldness
DK191889D0 (da) * 1989-04-20 1989-04-20 Bukh Meditec Kosmetisk middel
FR2646604B1 (fr) 1989-05-03 1994-02-04 Fabre Medicament Pierre Composition pour usage externe a base de sucralfate et son procede de preparation
DK86492D0 (da) 1992-06-30 1992-06-30 Bukh Meditec Laegemiddel
US7795239B2 (en) * 1992-07-27 2010-09-14 Mueller Medical International LLC Saccharide compositions and method of use
US20090215717A1 (en) * 2004-08-05 2009-08-27 Ivax Drug Research Institute Ltd. Sulfated oligosaccharides
FR2916355B1 (fr) * 2007-05-25 2009-08-28 Urgo Soc Par Actions Simplifie Nouveau principe actif dans la cicatrisation et son utilisation

Also Published As

Publication number Publication date
EP2714705A1 (fr) 2014-04-09
PL2714705T3 (pl) 2015-09-30
US9562065B2 (en) 2017-02-07
WO2012163997A1 (fr) 2012-12-06
ES2541476T3 (es) 2015-07-20
EP2714705B1 (fr) 2015-04-22
FR2975993A1 (fr) 2012-12-07
JP2014515388A (ja) 2014-06-30
US20140121180A1 (en) 2014-05-01
PT2714705E (pt) 2015-08-05
FR2975993B1 (fr) 2013-06-28

Similar Documents

Publication Publication Date Title
AU2021202759B2 (en) Peptides for use in promoting transport of glucose
JP2013521300A (ja) 抗菌ペプチド隔離化合物を用いた皮膚疾患および皮膚障害の処置のための組成物および方法
KR20100016450A (ko) 피부 외용제 조성물
AU2024211009A1 (en) Growth promoting peptides, and uses thereof
US20120245120A1 (en) Zinc sucrose octasulfates, their preparation, and pharmaceutical and cosmetic uses thereof
WO2017009488A1 (en) Topical compositions
WO2007132900A1 (ja) 皮膚保湿剤および皮膚炎治療剤
US20250352608A1 (en) Polypeptides having anti-inflammatory effects and uses thereof
JP5998211B2 (ja) マグネシウムのスクロースオクタ硫酸エステル、その製造方法およびその医薬的および美容的使用
EP3329905A1 (en) Topical cosmetic compositions comprising an oligopeptide against anti-aging of the skin
CN113766922A (zh) 用于炎症性皮肤病的硫酸葡聚糖
EP2714706A1 (fr) Sucroses octasulfates de calcium, leur préparation et leurs applications pharmaceutiques et cosmétiques
AU2017256698B2 (en) Amide derivatives of polycaffeoylquinic acids, process for producing same and uses thereof
JP2011020973A (ja) 難治性の皮膚潰瘍治療用の医薬組成物、及び、皮膚潰瘍予防用化粧料
CN113929750B (zh) 一种具有修复皮肤屏障功能的多肽及其应用
JP7396585B2 (ja) Ｔｓｌｐ遺伝子発現抑制用、ｉｌ－３３遺伝子発現抑制用、又はフィラグリン産生促進用組成物
JP2019011259A (ja) フィラグリン産生促進剤、ロリクリン産生促進剤、インボルクリン産生促進剤
CN104829678B (zh) 积雪草酸盐及其制备方法和用途
KR20170061084A (ko) 휴매닌 또는 이의 유사체를 유효성분으로 함유하는 창상 치료용 약학적 조성물
HK40063792A (en) Dextran sulfate for inflammatory dermatoses
CN119119322A (zh) 一种透明质酸丁酸酯复合物及其制备方法、应用
HK40073114A (en) Growth promoting peptides and uses thereof
KR20200122868A (ko) 대계 추출물을 유효성분으로 포함하는 피부상처 치유 또는 피부재생 촉진용 조성물
WO2008120264A1 (en) Use of misoprostol for the topic treatment of skin lesions by stings and burns
HK1182951A (en) Compositions and methods for treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150514

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20150514

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160415

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160706

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20160729

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160829

R150 Certificate of patent or registration of utility model

Ref document number: 5998211

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250